248 related articles for article (PubMed ID: 30962859)
21. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
22. Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.
Cumberbatch MG; Cox A; Teare D; Catto JW
JAMA Oncol; 2015 Dec; 1(9):1282-90. PubMed ID: 26448641
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
24. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
26. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
29. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
30. Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
Xiao YL; Wang K; Liu Q; Li J; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e48-e65. PubMed ID: 30470623
[TBL] [Abstract][Full Text] [Related]
31. Melanoma in individuals with neurofibromatosis type 1: a retrospective study.
Zhang M; Bhat T; Gutmann DH; Johnson KJ
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045143
[TBL] [Abstract][Full Text] [Related]
32. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
[TBL] [Abstract][Full Text] [Related]
34. Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.
Cohen PR
Cureus; 2021 Apr; 13(4):e14258. PubMed ID: 33954070
[TBL] [Abstract][Full Text] [Related]
35. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
36. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
38. Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis.
Agodirin O; Aremu I; Rahman G; Olatoke S; Olaogun J; Akande H; Romanoff A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1007-1017. PubMed ID: 33906291
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies.
Gennari A; Costa M; Puntoni M; Paleari L; De Censi A; Sormani MP; Provinciali N; Bruzzi P
Breast Cancer Res Treat; 2015 Apr; 150(2):405-13. PubMed ID: 25744295
[TBL] [Abstract][Full Text] [Related]
40. Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women.
Wang R; Yin Z; Liu L; Gao W; Li W; Shu Y; Xu J
Front Oncol; 2018; 8():427. PubMed ID: 30356721
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
